ERBB2 and triple-negative breast carcinoma: About 15 to 20 percent of breast tumors are triple-negative breast cancers (TNBC), which are defined by the absence of the progesterone receptor (PR), estrogen receptor (ER) and human epidermal growth factor receptor 2(HER2).